Spinal Cord Stimulation Utilization to Treat the Microcirculatory Vascular Insufficiency and Ulcers Associated with Scleroderma: A Case Report and Review of the Literature

Pain Medicine

Volumn 12, Issue 9, 2011, Pages 1331-1335

  Provenzano, David A ^a   Nicholson, Luke ^a   Jarzabek, Gaye ^a   Lutton, Evan ^a   Catalane, David B ^b   Mackin, Eileen ^b  

^a Institute for Pain Diagnostics and Care   (United States)

^b Ohio Valley General Hospital   (United States)

Author keywords

Raynaud's Phenomenon; Scleroderma; Spinal Cord Stimulation; Transcutaneous Oxygen Pressure

Indexed keywords

ADULT; ANALGESIA; ANKLE BRACHIAL INDEX; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC ULCER; MEDICAL HISTORY; MICROCIRCULATION; MICROCIRCULATORY VASCULAR INSUFFICIENCY; OXYGEN TENSION; POSTOPERATIVE PERIOD; RAYNAUD PHENOMENON; SCLERODERMA; SPINAL CORD STIMULATION; VASCULAR DISEASE;

EID: 80052864113     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01214.x     Document Type: Article

References (22)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360(19):1989-2003.
2. Kahaleh MB. Raynaud's phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 1995;7(6):529-34.
3. Wigley FM. Clinical practice. Raynaud's phenomenon. N Engl J Med 2002;347(13):1001-8.
4. Huber SJ, Vaglienti RM, Huber JS. Spinal cord stimulation in severe, inoperable peripheral vascular disease. Neuromodulation 2000;3(3):131-43.
5. Matsumoto Y, Ueyama T, Endo M, etal. Endoscopic thoracic sympathicotomy for Raynaud's phenomenon. J Vasc Surg 2002;36(1):57-61.
6. Flatt AE. Digital artery sympathectomy. J Hand Surg [Am] 1980;5(6):550-6.
7. Claes G, Drott C, Gothberg G. Thoracoscopic sympathicotomy for arterial insufficiency. Eur J Surg Suppl 1994;572:63-4.
8. de Trafford JC, Lafferty K, Potter CE, Roberts VC, Cotton LT. An epidemiological survey of Raynaud's phenomenon. Eur J Vasc Surg 1988;2(3):167-70.
9. Tanaka S, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Role of primary afferents in spinal cord stimulation-induced vasodilation: Characterization of fiber types. Brain Res 2003;959(2):191-8.
10. Tanaka S, Barron KW, Chandler MJ, Linderoth B, Foreman RD. Low intensity spinal cord stimulation may induce cutaneous vasodilation via CGRP release. Brain Res 2001;896(1-2):183-7.
11. Wu M, Linderoth B, Foreman RD. Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: A review of experimental studies. Auton Neurosci 2008;138(1-2):9-23.
12. Francaviglia N, Silvestro C, Maiello M, Bragazzi R, Bernucci C. Spinal cord stimulation for the treatment of progressive systemic sclerosis and Raynaud's syndrome. Br J Neurosurg 1994;8(5):567-71.
13. Deer TR. Spinal cord stimulation for the treatment of angina and peripheral vascular disease. Curr Pain Headache Rep 2009;13(1):18-23.
14. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 2005;(3):CD004001.
15. Fiume D. Spinal cord stimulation in peripheral vascular pain. Appl Neurophysiol 1983;46(5-6):290-4.
16. Neuhauser B, Perkmann R, Klingler PJ, etal. Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon. Am Surg 2001;67(11):1096-7.
17. Sibell DM, Colantonio AJ, Stacey BR. Successful use of spinal cord stimulation in the treatment of severe Raynaud's disease of the hands. Anesthesiology 2005;102(1):225-7.
18. Provenzano DA, Jarzabek G, Georgevich P. The utilization of transcutaneous oxygen pressures to guide decision-making for spinal cord stimulation implantation for inoperable peripheral vascular disease: A report of two cases. Pain Physician 2008;11(6):909-16.
19. Petrakis E, Sciacca V. Prospective study of transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation in diabetic patients with critical lower limb ischaemia. Int Angiol 2000;19(1):18-25.
20. Amann W, Berg P, Gersbach P, etal. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: Results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 2003;26(3):280-6.
21. Claeys LG, Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 1996;15(4):344-9.
22. Dowd GS, Linge K, Bentley G. Measurement of transcutaneous oxygen pressure in normal and ischaemic skin. J Bone Joint Surg Br 1983;65(1):79-83.